The goal of the Specimen Resources and Pathology Core (SPRC) is to provide superior technical expertiseto the investigators on this proposal. Experienced head and neck pathologists and cytopathologists will workclosely with each SPORE project as well as the Biostatistics and Administrative Cores to ensure efficient andhighly-coordinated procurement, archiving, and storage of human tissue samples. Continuouscommunication between the clinicians, scientists, research nurses, biostatisticians, and pathologists togetherwith established standardized operating procedures for all core activities will provide optimal tissue collectionand accurate processing, analysis, and storage of each sample. The SRPC will function as the mainrepository of patient specimens and will oversee specimen processing and histopathology. This Core willutilize and expand the already well-established tissue banking efforts at Emory University for translationalresearch. Histopathologic analysis by the Core pathologists will confirm the quality and presence of theexpected study tissue in research specimens. Selected cellular biomarkers will be explored usingimmunohistochemistry. These immunostains will be interpreted by core pathologists. Cytology specimenswill be generated, and cytopathologic support in processing and interpreting the specimens will be provided.In addition, animal study specimen processing, histopathology, immunohistochemistry, and pathologicinterpretive support will be provided.Taken together, the primary objectives of the Specimen Resources and Pathology Core are to:1) Facilitate the acquisition, preservation, analysis, and dispersal of clinical samples2) Provide accurate histopathological and cytological characterization of head and neck tissues for all projectinvestigators, thus providing uniform quality assurance3) Identify oral dyplasia biopsy specimens in the Oral, Head and Neck Biopsy service4) Offer reliable centralized laboratory services to the SPORE investigators with respect to tissue samplesthat include histochemistry, immunohistochemical staining, in-situ hybridization, and laser capturemicrodissectionBy assisting the researchers in these translational projects, we hope to advance the understanding of howoral cancer develops and aid in the development of treatment and preventive stategies for oral cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA128613-01
Application #
7300639
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$252,889
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gleber-Netto, Frederico O; Zhao, Mei; Trivedi, Sanchit et al. (2018) Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124:84-94
Wang, Xu; Beitler, Jonathan J; Huang, Wen et al. (2018) Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin. Clin Cancer Res 24:858-869
Pai, Sara I; Jack Lee, J; Carey, Thomas E et al. (2018) HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers. Oral Oncol 77:92-97
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188
Pike, Robert; Lu, Guolan; Wang, Dongsheng et al. (2016) A Minimum Spanning Forest-Based Method for Noninvasive Cancer Detection With Hyperspectral Imaging. IEEE Trans Biomed Eng 63:653-63
Majumdar, Debatosh; Rahman, Mohammad Aminur; Chen, Zhuo Georgia et al. (2016) Anticancer activity of drug conjugates in head and neck cancer cells. Front Biosci (Elite Ed) 8:358-69
Oh, Y-T; Deng, J; Yue, P et al. (2016) Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing. Oncogene 35:459-67
Oh, You-Take; Yue, Ping; Wang, Dongsheng et al. (2015) Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling. Oncotarget 6:41324-38
Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia et al. (2015) Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2. Apoptosis 20:986-95
Amin, A R M Ruhul; Haque, Abedul; Rahman, Mohammad Aminur et al. (2015) Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. PLoS One 10:e0124218

Showing the most recent 10 out of 136 publications